The challenge of CMC regulatory compliance for biopharmaceuticals /

Each year for the past three years, there have been about 50 new molecular medicines approved by the United States Food and Drug Administration (FDA), of which approximately 25% were new biopharmaceuticals. Over 200 recombinant proteins, monoclonal antibodies, antibody drug conjugates, fusion protei...

Full description